Scrip World Pharmaceutical News - Drug Delivery News
 
Scrip World Pharmaceutical News - Home

Latest Drug Delivery News

A higher dose nicotine patch, Nicorette Invisipatch, launched in the UK
For those contemplating a New Year resolution to quit smoking, McNeil Products (Johnson & Johnson) has just the thing: it is introducing a higher dose, 25mg nicotine patch, Nicorette Invisipatch, in the UK in January.
Monday 5 January 2009

NovaDel's zolpidem spray approved in the US
NovaDel's oral spray formulation of zolpidem tartrate, Zolpimist 5mg and 10mg, has been approved by the US FDA for the short-term treatment of insomnia characterised by difficulty in falling asleep.
Wednesday 31 December 2008

Glenmark expects early launch of Napo's crofelemer

Monday 29 December 2008

Archemix seals $1.4 billion deal with GSK
Archemix and GlaxoSmithKline are to develop seven aptamer therapeutics for inflammatory diseases in a deal worth $1.4 billion.
Monday 29 December 2008

Roche tapping Asian drug delivery expertise

Monday 22 December 2008

Prasugrel receives CHMP nod
The EU's CHMP has granted a positive opinion recommending approval of Lilly and Daiichi Sankyo's novel antiplatelet therapy prasugrel (Efient, 5mg and 10mg film-coated tablets), giving a boost to the product which has twice seen delays in its US approval process.
Monday 22 December 2008

AcelRx's sufentanil NanoTabs effective in pain

Thursday 18 December 2008

Taiwan links with AmVac for nasal bird flu vaccine
AmVac is to supply its novel adjuvant technology to Taiwan's National Health Research Institutes (NHRI) for use in a development-stage intranasal vaccine against the H5N1 bird flu virus.
Thursday 18 December 2008

Japan now part of global dapagliflozin alliance
AstraZeneca and Bristol-Myers Squibb have extended their global alliance for the development and commercialisation of dapagliflozin to Japan, the only country excluded from the original agreement.
Wednesday 10 December 2008

Bausch & Lomb eye US besifloxacin launch Bausch & Lomb eyes US besifloxacin launch following panel endorsement
Bausch & Lomb's novel fluoroquinolone Optura (besifloxacin ophthalmic suspension, 0.6%) should be approved for treating bacterial conjunctivitis, the US FDA's outside experts said on December 5th.
Tuesday 9 December 2008

Previous 1 2 3 4 5 6 7 8 9 10 11 Next

Email to a friend

About Scrip

Scrip World Pharmaceutical News provides you with high quality news coverage of pharma and biotech and also gives you strategic data and analysis.

Subscribe to Scrip World Pharmaceutical News today!Benefits include:

›› Daily email headlines

›› Searchable news
archive

›› Weekly copies of Scrip

›› Bespoke Scrip supplements

›› Plus the Scrip Yearbook
and Scrip League Tables

Scrip Awards 2008

The best and brightest of the pharmaceutical and biotech industries were celebrated at a glittering ceremony in London at the 2008 Scrip Awards.

Read the full story

Scrip Directory

Scrip Directory 2008

Search over 20,000 international contacts and access potential business opportunities